Novavax Inc (NASDAQ:NVAX)
| 41.58 BATS BZX Real-Time Price As of 2:41pm ET |  +1.30 / +3.23%Today’s Change | 34.88 Today|||52-Week Range 277.80 | -70.94% Year-to-Date |
Latest NVAX News | Press Releases
| 3 Companies Growing Revenue Fast 1:23pm / GuruFocus News - Paid Partner Content | Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half Aug 09 / Zacks.com - Paid Partner Content |
| 1 Reason to Sell Novavax Stock, and 1 Reason to Buy 1:15pm / MotleyFool.com - Paid Partner Content | Reata (RETA) Q2 Earnings Miss, Revenues Down Y/Y, Stock Down Aug 09 / Zacks.com - Paid Partner Content |
| Bausch (BHC) Q2 Earnings & Sales Miss, View Cut, Stock Down 11:56am / Zacks.com - Paid Partner Content | Apellis (APLS) Q2 Earnings and Sales Miss Estimates, Stock Down Aug 09 / Zacks.com - Paid Partner Content |
| Stock Market News for Aug 10, 2022 9:31am / Zacks.com - Paid Partner Content | Why Novavax Stock Is Plunging Today Aug 09 / MotleyFool.com - Paid Partner Content |
| Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026 5:21am / MotleyFool.com - Paid Partner Content | Novavax Stock Is Crashing: These 3 Words Explain Why Aug 09 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 40.28 |
| Today’s open | 40.04 |
| Day’s range | 38.50 - 41.61 |
| Volume | 172,238 |
| Average volume (3 months) | 6,792,076 |
| Market cap | $4.6B |
Data as of 2:41pm ET, 08/10/2022
Growth & Valuation
| Earnings growth (last year) | -222.51% |
| Earnings growth (this year) | +203.61% |
| Earnings growth (next 5 years) | +36.40% |
| Revenue growth (last year) | +141.02% |
| P/E ratio | NM |
| Price/Sales | 9.29 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | -0.31 | -0.94% |
| ---- | ||
| ARVNArvinas Inc | +1.78 | +3.19% |
| ---- |
Data as of 2:40pm ET, 08/10/2022
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | $4.80 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$1.7B |
| Net profit margin | -152.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
